
Tim F. Greten, MD, discusses the role of the gut microbiome in antitumor immunity in liver cancer.

Tim F. Greten, MD, discusses the role of the gut microbiome in antitumor immunity in liver cancer.

Tim F. Greten, MD, senior investigator, Thoracic and Gastrointestinal Malignancies Branch, National Cancer Institute, discusses the impact of the gut microbiome on liver tumors.

Tim F. Greten, MD, senior investigator thoracic and gastrointestinal oncology branch, head, gastrointestinal malignancy section, National Cancer Institute, discusses promising immunotherapy agents being investigated in hepatocellular carcinoma (HCC).

Tim F. Greten, MD, senior investigator thoracic and gastrointestinal oncology branch, head, gastrointestinal malignancy section, National Cancer Institute (NCI), discusses the potential for immunotherapy in hepatocellular carcinoma (HCC).

May 19th 2017

December 11th 2018

September 30th 2019

November 13th 2016